Better Dividend Stock: Pfizer vs. AbbVie
Income-seeking investors usually don't think of the innovation-dependent pharmaceutical industry as a place to look for businesses with reliable cash flows.
Dividend seekers have a good reason to be cautious regarding drugmaker stocks. Profit driven by patent-protected market exclusivity can disappear in the blink of an eye after those patents expire.
Image source: Getty Images.
Source Fool.com
